BioSpace News Archive

The CNS Summit Announces Top 10 on 2nd Annual CNS Summit Innovation Index

The CNS Summit has released the 2017 CNS Summit Innovation Index.

November 28, 2017

·

1 min read

Business

Accelerate Diagnostics Joins Sepsis Alliance in Global #GivingTuesday Movement to Raise Awareness of Sepsis as Medical Emergency

Accelerate Diagnostics has pledged to match the first $10,000 gifted to Sepsis Alliance on #GivingTuesday to help raise awareness of sepsis as an often preventable medical emergency.

November 28, 2017

·

3 min read

Genetown

TESARO Announces Availability of VARUBI (rolapitant) IV for Delayed Nausea and Vomiting Associated With Cancer Chemotherapy in the United States

The U.S. Food and Drug Administration (FDA) approved VARUBI injectable emulsion on October 25, 2017.

November 28, 2017

·

11 min read

GN Store Nord A/S: Transactions in Relation to Share Buyback Program – Nov. 28, 2017

The share buyback program has been initiated in order to reduce the company’s share capital and to cover obligations under the long-term incentive program.

November 28, 2017

·

2 min read

Biotech Beach

DeepRadiology Announces the World’s First CT Head System With Performance Exceeding Radiologists

The system is able to detect clinically significant pathologies in CT scans of the head with error rates better than published error rates for radiologists.

November 28, 2017

·

1 min read

Policy

Deciphera Pharmaceuticals Announces Orphan Drug Designation from the EMA for DCC-2618 for the Treatment of Gastrointestinal Stromal Tumors

The company announced that the European Medicines Agency (EMA) has granted orphan drug designation (ODD) to DCC-2618, the Company’s pan-KIT and PDGFRα inhibitor, for the treatment of gastrointestinal stromal tumors (GIST).

November 28, 2017

·

6 min read

Business

G1 Therapeutics and AstraZeneca Enter Clinical Trial Collaboration in Non-Small Cell Lung Cancer

Phase 1b/2 study evaluating AstraZeneca’s Tagrisso® and G1T38 in EGFR mutation-positive non-small cell lung cancer is expected to initiate in the first quarter of 2018.

November 28, 2017

·

5 min read

Genetown

ReWalk Robotics Announces Full Exercise of Underwriter’s Option to Purchase Additional Ordinary Shares in Follow-on Public Offering

After the exercise of the option, the total number of ordinary shares sold by ReWalk in the offering increased from 6,857,000 to 7,885,550.

November 28, 2017

·

5 min read

Business

Auris Medical Reports Third Quarter 2017 Financial Results and Provides Business Update

Cash and cash equivalents at September 30, 2017, totaled CHF 20.2 million.

November 28, 2017

·

10 min read

Business

Telcare, a Division of BioTelemetry, Announces Collaboration With Onduo in Diabetes Management Program

Telcare will serve as the supplier of remote blood glucose systems and the resulting data for patients enrolled in Onduo’s groundbreaking diabetes management program.

November 28, 2017

·

3 min read